Dubai PR Network, Online Press Release from Dubai and Middle East
 
Healthcare(Healthcare & Medicine)
Filter PR by
  

NYU Abu Dhabi Researchers Design Proteins That Can Be Utilized to Combat Alzheimer's Disease

 
NYU Abu Dhabi Researchers Design Proteins That Can Be Utilized to Combat Alzheimer's Disease
Protein-based therapeutics prevent protein aggregation associated with Alzheimer’s and other neurodegenerative diseases
 
Fast facts
● Alzheimer’s disease, an irreversible and progressive brain disorder, is the most common cause of dementia. 
● A hallmark of Alzheimer’s disease is the aggregation of the amyloid-β (Aβ) protein in a process that is toxic to the brain’s neurons. As neurons die, this slowly destroys memory and cognitive function. 
● NYUAD researchers have developed small proteins called cell-penetrating peptides (CPPs) that prevent the aggregation of the Aβ protein. 
● The paper Designed cell-penetrating peptide inhibitors of amyloid-beta aggregation and cytotoxicity has been published in Cell Reports Physical Science.
 
Abu Dhabi, UAE, February 7, 2020: A team of researchers, led by NYU Abu Dhabi Assistant Professor of Biology Mazin Magzoub, has developed small proteins called cell-penetrating peptides (CPPs) that prevent the aggregation of the amyloid-β (Aβ) protein associated with Alzheimer’s disease. 
 
There is a growing interest in the use of proteins to develop treatments because they are biocompatible, biodegradable, and can selectively bind to specific targets, which reduces the potential for toxicity. Other pharmaceutically-desirable properties of proteins include greater chemical diversity than other biological molecule classes, and ease and low cost of production. However, a significant obstacle to the successful application of most proteins as therapeutics is their poor delivery to target organs and cells. 
 
In a new study, the Magzoub lab in collaboration with Professor and NYU President Andrew Hamilton’s lab at NYU New York and Professor Astrid Gräslund’s lab at Stockholm University, report that they have engineered CPPs that effectively prevent the aggregation of Aβ. CPPs are a special class of proteins that have the ability to reach all organs, including the brain, and to efficiently enter cells within these organs. Thus, the designed CPPs combine the attractive properties of proteins with potent therapeutic effects and highly efficient delivery to target cells.
 
A broad range of neurodegenerative diseases, including Huntington’s, Parkinson’s, and Alzheimer’s, are caused by the misfolding of disease-specific proteins. Once misfolded, these proteins build up in a process that damages neurons. Previously, the team showed that a naturally-derived CPP was able to protect against abnormal and harmful forms of the protein associated with prion diseases, a class of neurodegenerative disorders that include mad cow disease in cattle and Creutzfeldt-Jakob disease (CJD) in humans. Here, Magzoub and his collaborators extended this approach and specifically applied it to Alzheimer’s disease-causing Aβ malformation. 
 
In the paper titled Designed cell-penetrating peptide inhibitors of amyloid-beta aggregation and cytotoxicity, the researchers present the process of designing the Aβ inhibitor CPPs. Using a range of techniques, they then extensively characterized the interactions of the designed CPPs with Aβ. Specifically, they used established aggregation and cell viability assays to determine the effects of the designed CPPs on the aggregation and associated neurotoxicity of Aβ. Simultaneously, they probed the cellular uptake and intracellular distribution of Aβ in the presence of the CPPs with confocal fluorescence microscopy. Finally, they used a combination of experiments and computer simulations to shed light on the mechanism of binding of the CPPs to Aβ. The results show that the designed CPPs stabilize the Aβ protein in a non-aggregated, non-abnormal state, and inhibit Aβ induced neurotoxicity.
 
The CPPs designed in this study effectively target Aβ outside and inside neurons, thereby protecting them against the damage caused by Aβ aggregation. “The designed CPPs represent a novel potential treatment strategy for Alzheimer’s disease,” said Magzoub. “These findings also reveal a general underlying principle for inhibition of pathogenic protein aggregation that will facilitate the design of even more potent CPP-based therapeutics for various neurodegenerative diseases.”


Posted by : DubaiPRNetwork.com Editorial Team
Viewed 14083 times
PR Category : Healthcare & Medicine
Posted on : Saturday, February 8, 2020  9:03:00 AM UAE local time (GMT+4)
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of DubaiPRNetwork.com.
Previous Story : Aster DM Healthcare Wins 6 Awards at AHPI Awards 2020
Next Story : Aster Hospitals Dubai achieves diamond level status from Acc...
Email this article Print this article

Share this article with your friends and followers
NewsVine
Back to Section Home

Related Stories



 
 
Most Viewed Press Release posted in the last 7 days
Royal Jordanian flight touches down in ancient city of AlUla inaugurating new direct route [27777-Views]
STATEMENT BY PRINCIPALS OF THE INTER-AGENCY STANDING COMMITTEE - CIVILIANS IN GAZA IN EXTR... [25625-Views]
IATA and The Weather Company Collaborate to Provide Enhanced Turbulence-Related Weather Da... [25391-Views]
CARTIER ISLAMIC INSPIRATION AND MODERN DESIGN EXHIBITION AT LOUVRE ABU DHABI [7027-Views]
e& reports record consolidated net profit of AED 10.3 billion growing 3% year-over-year [6662-Views]
Louis Vuitton Tops the Global Powers of Luxury Goods 2023 List by Deloitte; Malabar Gold &... [6404-Views]
Landmark Group's Beat Diabetes Walk: A Milestone Event Supporting Dubai Social Agenda 33 [6339-Views]
Presenting the new Bremont Bamford Aurora Limited Edition [6269-Views]
Ministry of Finance announces the issuance of a federal decree-law concerning federal prop... [6015-Views]
The Constellation Meteorite: No Two Dials the Same [5888-Views]
Gulfood to lead the way on where the F&B industry goes next, driving investment, competiti... [5748-Views]
ACE MENTORS! US OPEN DOUBLES CHAMPIONS RALLY WITH UAE KIDS AS PART OF DUBAI COACHING CLINI... [5711-Views]
Dubai Department of Economy and Tourism showcases a range of products, services and invest... [5432-Views]
Luxury Perfumery Pioneer Navitus Parfums Launches in Dubai [5338-Views]
Dubai Customs Raises Awareness among 5150 Cruise Ship Passengers about Its Measures to Com... [5141-Views]
Monty Capital Achieves Key Regulatory Milestone With The Acquisition Of DFSA Category 4 Li... [5113-Views]
DHA launches ĎAssessment of Critical Care and Emergency Transfer Services' Project with He... [4969-Views]
29th edition of Gulfood, world's largest F&B sourcing event, commences in DWTC [4887-Views]
Hotpack Global to roll out RECAPP recycling bins to collect 40 tons of waste a year [4883-Views]
Union Coop Announces Ramadan 2024 Promotions [4871-Views]
Middle East airports expanding in a fast-forward mode to handle zooming passenger numbers [4768-Views]
Hakoora Invites Diners to Savour a Tempting Iftar Experience this Ramadan [4764-Views]
Recognising Team Effort: Dubai Airports launches OneDXB Chairman Award to celebrate delive... [4711-Views]
Dubai's Healthcare Sector Witnesses Extraordinary Growth in Facilities and Workforce [4600-Views]
Challenge Handling: Largest GHA in Liege Announces Major Developments for 2024 [4563-Views]
 
RSS Facebook Twitter LinkedDin DubaiPRNetwork.com on Instagram
 
Top Sections
 
Top Stories